NBCD A/S: Financial statements 2015
CVR: 30582462
Source: annual report 2015, Danish Business Authority
01/01/2015 – 31/12/2015
NBCD A/S (CVR 30582462) has filed annual accounts for 2015. In 2015, the company reported a gross profit of DKK -6,080,089 and a net result of DKK 37,890,921 compared with DKK 29,158,907 the year before. Equity in the 2015 report amounted to DKK 44,186,096. The solvency ratio was 41.5%.
- Gross Profit
- DKK -6,080,089
- Profit/Loss
- DKK 37,890,921
- Equity
- DKK 44,186,096
- Total Assets
- DKK 106,518,996
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2015 | - | -6.1 mio. | 37.9 mio. | 44.2 mio. | - |
| 2014 | - | 1.6 mio. | 29.2 mio. | 6.3 mio. | - |
| 2013 | - | -3.4 mio. | -11.8 mio. | -22.9 mio. | - |
| 2012 | - | - | - | 500 t. | - |
Official annual report
How creditworthy is NBCD A/S?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2015
NBCD A/S has published its annual report for 2014. Gross profit came to DKK 1,579,482, and the net result was DKK 29,158,907.
About NBCD A/S
NBCD A/S is a Danish company of the type Aktieselskab based in Søborg, founded in 2007. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named NORDIC BIOSCIENCE CLINICAL DEVELOPMENT A/S and NORDIC BIOSCIENCE PROJECT 2 A/S. The management consists of Jeppe Ragnar Andersen and Mark Høgh Gandrup. The board consists of Pierre Khaitrine (chair), Jeppe Ragnar Andersen and José Ignacio Pfeifer. The company is owned by Sanos Holding A/S. The company has 24 employees (2018). In 2025, the company reported a gross profit of DKK 31,583,144 and a net result of DKK 9,222,892 compared with DKK 52,621,101 the year before. Equity in the 2025 report amounted to DKK 136,144,994.